Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion type Assertion NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_head.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion description "[The CD34+ restricted pattern of expression of CML28 and CML66 is particularly relevant in light of the notion that DLI likely exerts its curative effect by targeting antigens present in self-renewing malignant progenitor populations in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_provenance.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion evidence source_evidence_literature NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_provenance.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion SIO_000772 15958636 NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_provenance.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion wasDerivedFrom befree-20150227 NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_provenance.
- NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_assertion wasGeneratedBy ECO_0000203 NP958703.RAJZ2R7eNqNmF-cwg9teyansVSbQmG0vKbJ8mQhraclBI130_provenance.